← Evidence map

TrialEpilepsia2023

Fenfluramine provides clinically meaningful reduction in frequency of drop seizures in patients with Lennox-Gastaut syndrome: Interim analysis of an open-label extension study.

Kelly G Knupp et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

34 papers cite it

2022
2023
2024
2025
2026
this paperpooled ittrialcites it

The trial

Full record →Abstract, authors, funding and every citing paper · PMID 36196777